MedStar Health
Welcome,         Profile    Billing    Logout  
 1 Trial 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Smith, Jamal
CAPTIVA, NCT05047172: Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

Recruiting
3
1683
US
Ticagrelor + Aspirin, Brilinta, Rivaroxaban + Aspirin, Xarelto, Clopidogrel + Aspirin, Plavix, Risk Factor Management
University of Florida, National Institute of Neurological Disorders and Stroke (NINDS), University of Cincinnati, Medical University of South Carolina, Janssen Scientific Affairs, LLC, AstraZeneca
Intracranial Arteriosclerosis, Stroke
05/27
05/27
NCT05663853: An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Completed
N/A
137
US
LAPIX Therapeutics Inc.
Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive
04/24
04/24
Shin, Robert
NCT05285891: Ocrelizumab Discontinuation in Relapsing Multiple Sclerosis

Recruiting
4
175
US
Ocrelizumab, Ocrevus, Placebo for Ocrelizumab
National Institute of Allergy and Infectious Diseases (NIAID), Autoimmunity Centers of Excellence (ACE), Rho Federal Systems Division, Inc., Genentech, Inc.
Multiple Sclerosis
08/28
08/28
NCT05663853: An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Completed
N/A
137
US
LAPIX Therapeutics Inc.
Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive
04/24
04/24

Download Options